Markets Jolted as Moderna Says COVID Shots Weaker Against Omicron

HONG KONG/SYDNEY — The chief executive of drugmaker Moderna set off fresh alarm bells in financial markets on Tuesday with a warning that existing COVID-19 vaccines would be less effective against the Omicron variant than they have been against the Delta variant. Read More